In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract.

Recent reports have suggested that mesenchymal cells derived from bone marrow may differentiate into not only mesenchymal lineage cells but also other lineage cells. There is possibility for insulin-producing cells (IPCs) to be differentiated from mesenchymal cells. We used self-functional repair stimuli of stem cells by partial injury. Rat pancreatic extract (RPE) from the regenerating pancreas (2 days after 60% pancreatectomy) was treated to rat mesenchymal cells. After the treatment of RPE, they made clusters like islet of Langerhans within a week and expressed four pancreatic endocrine hormones; insulin, glucagon, pancreatic polypeptide, and somatostatin. Moreover, IPCs released insulin in response to normal glucose challenge. Here we demonstrate that the treatment of RPE can differentiate rat mesenchymal cells into IPCs which can be a potential source for the therapy of diabetes.

[1]  Seung K. Kim,et al.  Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Kawamori,et al.  Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells , 2003, Diabetologia.

[3]  M. Hussain,et al.  In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion , 2003 .

[4]  I. Black,et al.  Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis , 2002, Journal of neuroscience research.

[5]  B. Petersen,et al.  In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Stoffel,et al.  Bone marrow: an extra-pancreatic hideout for the elusive pancreatic stem cell? , 2003, The Journal of clinical investigation.

[7]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[8]  Lan Wang,et al.  No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. , 2004, Diabetes.

[9]  Hyun-Jung Kim,et al.  Enhancement of mouse pancreatic regeneration and HIT-T15 cell proliferation with rat pancreatic extract. , 2003, Biochemical and biophysical research communications.

[10]  Chan‐Wha Kim,et al.  Ethanol decreases basal insulin secretion from HIT-T15 cells. , 2002, Life sciences.

[11]  S. Bae,et al.  Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes , 2004, Laboratory Investigation.

[12]  D. Schatz,et al.  Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells , 2000, Nature Medicine.

[13]  S. Bonner-Weir,et al.  In vitro cultivation of human islets from expanded ductal tissue. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2002, Nature.

[15]  W. Mars,et al.  Bone marrow as a potential source of hepatic oval cells. , 1999, Science.

[16]  A. Hardikar,et al.  Modulating experimental diabetes by treatment with cytosolic extract from the regenerating pancreas. , 1999, Diabetes research and clinical practice.

[17]  R. McKay,et al.  Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic Islets , 2001, Science.

[18]  M. Raff,et al.  Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. , 2000, Science.